Version history

{
  "session_id": "sess_hypdebate_h_var_7c976d9fb7_20260427_162236",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "content": "\n\n## Theoretical Analysis: TREM2-Mediated Microglial Dysfunction and Perivascular Tau Clearance\n\n### Key Molecular Mechanisms\n\n**TREM2 Signaling Cascade**: TREM2 activates via TYROBP/DAP12 adaptor protein, triggering SYK kinase recruitment and downstream PI3K/AKT signaling. This pathway controls microglial survival, proliferation, and phagocytic capacity (Wang et al., Cell 2015; PMID: 26646038).\n\n**Perivascular Niche Dynamics**: Perivascular microglia occupy strategic positions near cerebral blood vessels, where they interact with the glymphatic system. Iliff et al. demonstrated perivascular pathways are critical for CNS solute clearance (PMID: 22878717). Tau propagation along these routes has been documented in both rodent models and human tissue (Katsinlos et al., Nat Neurosci 2022; PMID: 35132231).\n\n**Mechanistic Link**: TREM2-mediated phagocytosis deficiency would impair microglial clearance of extracellular tau species in perivascular spaces, enabling Templar propagation along vascular corridors.\n\n### Testable Predictions\n\n1. **Phagocytosis Assay**: TREM2 knockout or R47H variant microglia will show reduced uptake of fluorescently-labeled tau fibrils in vitro compared to wild-type cells, with greater impairment for perivascular-localized microglia populations.\n\n2. **In Vivo Clearance Model**: TREM2-deficient mice injected with exogenous tau will exhibit prolonged perivascular tau retention, quantified via two-photon imaging of pial vessels, relative to controls.\n\n3. **AD Model Validation**: In 3xTg or P301S mice, crossing with TREM2 knockout animals will demonstrate increased perivascular tau deposits and accelerated spreading patterns.\n\n### Prior Literature Support\n\n- TREM2 R47H increases AD risk 3-4 fold (Jonsson et al., NEJM 2013; PMID: 23644042)\n- TREM2 loss-of-function impairs amyloid plaque compaction (Ulland et al., Cell 2017; PMID: 28800989)\n- Microglial deficiency exacerbates tau pathology (Gratuze et al., J Exp Med 2018; PMID: 29222112)\n\n**Caveat**: The hypothesis would be strengthened by direct evidence that perivascular microglia are uniquely TREM2-dependent, as tissue-resident microglia show regional transcriptional heterogeneity."
}